| Year |
Citation |
Score |
| 2024 |
Ulaner GA, VanderMolen LA, Li G, Ferreira D. Dotatate PET/CT and Ac-Dotatate Therapy for Somatostatin Receptor-expressing Metastatic Breast Cancer. Radiology. 312: e233408. PMID 39078299 DOI: 10.1148/radiol.233408 |
0.321 |
|
| 2024 |
Vaz SC, Woll JPP, Cardoso F, Groheux D, Cook GJR, Ulaner GA, Jacene H, Rubio IT, Schoones JW, Peeters MV, Poortmans P, Mann RM, Graff SL, Dibble EH, de Geus-Oei LF. Joint EANM-SNMMI guideline on the role of 2-[F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). European Journal of Nuclear Medicine and Molecular Imaging. PMID 38740576 DOI: 10.1007/s00259-024-06696-9 |
0.304 |
|
| 2024 |
Ulaner GA, Vaz SC. Women's Health Update: Growing Role of PET for Patients with Breast Cancer. Seminars in Nuclear Medicine. 54: 247-255. PMID 38365547 DOI: 10.1053/j.semnuclmed.2024.01.007 |
0.302 |
|
| 2024 |
Yeh R, O'Donoghue JA, Jayaprakasam VS, Mauguen A, Min R, Park S, Brockway JP, Bromberg JF, Zhi WI, Robson ME, Sanford R, Modi S, Agnew BJ, Lyashchenko SK, Lewis JS, ... Ulaner GA, et al. First-in-Human Evaluation of Site-Specifically Labeled Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 38272704 DOI: 10.2967/jnumed.123.266392 |
0.303 |
|
| 2023 |
Fardanesh R, Beavers K, Jochelson MS, Ulaner GA. Value of subspecialist second opinion reads of 18F-FDG PET-CT examinations for patients with breast cancer. Nuclear Medicine Communications. PMID 37395540 DOI: 10.1097/MNM.0000000000001726 |
0.321 |
|
| 2023 |
Cecil K, Huppert L, Mukhtar R, Dibble EH, O'Brien SR, Ulaner GA, Lawhn-Heath C. Metabolic Positron Emission Tomography in Breast Cancer. Pet Clinics. PMID 37369614 DOI: 10.1016/j.cpet.2023.04.004 |
0.322 |
|
| 2020 |
Ulaner GA, Muehlbauer S, Goldberg Z. Acute Aortic Dissection Initially Suspected on 18F-FDG PET/CT. Clinical Nuclear Medicine. PMID 32701812 DOI: 10.1097/Rlu.0000000000003209 |
0.391 |
|
| 2020 |
Ulaner GA, Carrasquillo JA, Riedl CC, Yeh R, Hatzoglou V, Ross DS, Jhaveri K, Chandarlapaty S, Hyman DM, Zeglis BM, Lyashchenko SK, Lewis JS. Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted Zr-Pertuzumab PET/CT. Radiology. 192828. PMID 32515679 DOI: 10.1148/Radiol.2020192828 |
0.397 |
|
| 2020 |
Ulaner GA, Sobol NB, O'Donoghue JA, Kirov AS, Riedl CC, Min R, Smith E, Carter LM, Lyashchenko SK, Lewis JS, Landgren CO. CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging. Radiology. 192621. PMID 32255416 DOI: 10.1148/Radiol.2020192621 |
0.349 |
|
| 2020 |
Ulaner GA, Landgren CO. Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders. Best Practice & Research. Clinical Haematology. 33: 101148. PMID 32139013 DOI: 10.1016/J.Beha.2020.101148 |
0.386 |
|
| 2020 |
Ulaner GA. The QIBA Profile for FDG PET/CT: Improving the Value of PET. Radiology. 192409. PMID 31910074 DOI: 10.1148/Radiol.2019192409 |
0.386 |
|
| 2019 |
Kirchner J, Riedl CC, Ulaner GA. Patient Repositioning Reveals a Malignant Pleura Effusion Initially Mistaken as a Bone Metastasis on 18FDG PET/CT. Clinical Nuclear Medicine. 44: 969-970. PMID 31689279 DOI: 10.1097/RLU.0000000000002804 |
0.319 |
|
| 2019 |
Ulaner GA, Saura C, Piha-Paul SA, Mayer IA, Quinn DI, Jhaveri K, Stone B, Shahin S, Mann G, Dujka M, Bryce R, Meric-Bernstam F, Solit DB, Hyman DM. Impact of FDG PET Imaging for Expanding Patient Eligibility & Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31548342 DOI: 10.1158/1078-0432.Ccr-19-1658 |
0.36 |
|
| 2019 |
Ulaner GA. PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact? Ajr. American Journal of Roentgenology. 1-12. PMID 31063423 DOI: 10.2214/Ajr.19.21177 |
0.443 |
|
| 2019 |
Ulaner GA, Bodei L. Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT. Clinical Nuclear Medicine. PMID 30688738 DOI: 10.1097/Rlu.0000000000002467 |
0.341 |
|
| 2018 |
Ulaner GA, Juarez J, Riedl C, Goldman D. F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30237211 DOI: 10.2967/Jnumed.118.217836 |
0.426 |
|
| 2018 |
McDonald ES, Ulaner GA. Uses and Opportunities for Molecular Imaging in Patients with Breast Cancer. Pet Clinics. 13: xi-xii. PMID 30100083 DOI: 10.1016/J.Cpet.2018.05.001 |
0.302 |
|
| 2018 |
Ulaner GA, Schuster DM. Amino Acid Metabolism as a Target for Breast Cancer Imaging. Pet Clinics. 13: 437-444. PMID 30100081 DOI: 10.1016/J.Cpet.2018.02.009 |
0.316 |
|
| 2018 |
Henry KE, Ulaner GA, Lewis JS. Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer. Pet Clinics. 13: 423-435. PMID 30100080 DOI: 10.1016/J.Cpet.2018.02.010 |
0.367 |
|
| 2018 |
Chakraborty D, Basu S, Ulaner GA, Alavi A, Kumar R. Diagnostic Role of Fluorodeoxyglucose PET in Breast Cancer: A History to Current Application. Pet Clinics. 13: 355-361. PMID 30100075 DOI: 10.1016/j.cpet.2018.02.011 |
0.337 |
|
| 2018 |
Provenzano E, Ulaner GA, Chin SF. Molecular Classification of Breast Cancer. Pet Clinics. 13: 325-338. PMID 30100073 DOI: 10.1016/J.Cpet.2018.02.004 |
0.312 |
|
| 2018 |
Li BT, Shen R, Buonocore D, Olah ZT, Ni A, Ginsberg MS, Ulaner GA, Offin M, Feldman D, Hembrough T, Cecchi F, Schwartz S, Pavlakis N, Clarke S, Won HH, et al. Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018779777. PMID 29989854 DOI: 10.1200/Jco.2018.77.9777 |
0.313 |
|
| 2018 |
Mahajan S, Goel R, Riedl C, Ulaner GA. Mazabraud's Syndrome Mimicking Metastases on FDG PET/CT in a Patient With Colon Cancer. Clinical Nuclear Medicine. PMID 29863575 DOI: 10.1097/Rlu.0000000000002151 |
0.394 |
|
| 2017 |
Ulaner GA, Lyashchenko SK, Riedl C, Ruan S, Zanzonico PB, Lake D, Jhaveri K, Zeglis B, Lewis JS, O'Donoghue JA. First-in-human HER2-targeted imaging using (89)Zr-pertuzumab PET/CT: Dosimetry and clinical application in patients with breast cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29146695 DOI: 10.2967/Jnumed.117.202010 |
0.428 |
|
| 2017 |
Henry KE, Ulaner GA, Lewis JS. Human Epidermal Growth Factor Receptor 2-Targeted PET/Single- Photon Emission Computed Tomography Imaging of Breast Cancer: Noninvasive Measurement of a Biomarker Integral to Tumor Treatment and Prognosis. Pet Clinics. 12: 269-288. PMID 28576166 DOI: 10.1016/J.Cpet.2017.02.001 |
0.405 |
|
| 2017 |
Riedl CC, Pinker K, Ulaner GA, Ong LT, Baltzer P, Jochelson MS, McArthur HL, Gönen M, Dickler M, Weber WA. Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28462446 DOI: 10.1007/S00259-017-3703-7 |
0.423 |
|
| 2017 |
Ulaner GA, Castillo R, Wills J, Gönen M, Goldman DA. (18)F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28456837 DOI: 10.1007/S00259-017-3709-1 |
0.403 |
|
| 2017 |
Ulaner GA, Mannelli L, Dunphy M. Value of second-opinion review of outside institution PET-CT examinations. Nuclear Medicine Communications. 38: 306-311. PMID 28291158 DOI: 10.1097/Mnm.0000000000000647 |
0.379 |
|
| 2017 |
Ulaner GA, Sawan P. Transient Osteoporosis of the Hip on FDG PET/CT. Clinical Nuclear Medicine. PMID 28240672 DOI: 10.1097/Rlu.0000000000001630 |
0.379 |
|
| 2017 |
Ulaner GA, Zindman AM, Zheng J, Kim TW, Healey JH. FDG PET/CT Assesses the Risk of Femoral Pathological Fractures in Patients With Metastatic Breast Cancer. Clinical Nuclear Medicine. PMID 28166159 DOI: 10.1097/Rlu.0000000000001580 |
0.3 |
|
| 2016 |
Hogan MP, Osborne J, Ulaner GA. FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate. Clinical Nuclear Medicine. PMID 27805919 DOI: 10.1097/Rlu.0000000000001440 |
0.378 |
|
| 2016 |
Ulaner GA, Samstein R, Cahlon O, Weber WA, Rimner A. Unilateral Suppression of Brown Fat on FDG PET/CT in Horner Syndrome. Clinical Nuclear Medicine. PMID 27454597 DOI: 10.1097/Rlu.0000000000001319 |
0.349 |
|
| 2016 |
Marinelli B, Espinet-Col C, Ulaner GA, McArthur HL, Gonen M, Jochelson M, Weber WA. Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients. American Journal of Nuclear Medicine and Molecular Imaging. 6: 120-7. PMID 27186439 |
0.323 |
|
| 2016 |
Shady W, Kishore S, Gavane S, Do RK, Osborne JR, Ulaner GA, Gonen M, Ziv E, Boas FE, Sofocleous CT. Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0. European Journal of Radiology. 85: 1224-31. PMID 27161074 DOI: 10.1016/J.Ejrad.2016.03.029 |
0.37 |
|
| 2016 |
Ulaner GA, Hyman D, Ross D, Corben A, Chandarlapaty S, Goldfarb S, McArthur H, Erinjeri J, Solomon S, Kolb H, Lyashchenko S, Lewis J, Carrasquillo J. Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using the 89Zr-DFO-trastuzumab PET/CT. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27151988 DOI: 10.2967/Jnumed.115.172031 |
0.403 |
|
| 2016 |
Ulaner GA, Castillo R, Goldman DA, Wills J, Riedl CC, Pinker-Domenig K, Jochelson MS, Gönen M. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27129866 DOI: 10.1007/S00259-016-3402-9 |
0.416 |
|
| 2016 |
Ulaner GA, Goldman D, Gonen M, Pham H, Castillo R, Lyashchenko S, Lewis J, Dang C. Initial results of a prospective clinical trial of 18F-Fluciclovine PET/CT in newly diagnosed invasive ductal and invasive lobular breast cancers. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26940766 DOI: 10.2967/Jnumed.115.170456 |
0.386 |
|
| 2015 |
Hatzoglou V, Yang TJ, Omuro A, Gavrilovic I, Ulaner G, Rubel J, Schneider T, Woo KM, Zhang Z, Peck KK, Beal K, Young RJ. A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation. Neuro-Oncology. PMID 26688076 DOI: 10.1093/Neuonc/Nov301 |
0.344 |
|
| 2015 |
Jochelson MS, Lebron L, Jacobs SS, Zheng J, Moskowitz CS, Powell SN, Sacchini V, Ulaner GA, Morris EA, Dershaw DD. Detection of Internal Mammary Adenopathy in Patients With Breast Cancer by PET/CT and MRI. Ajr. American Journal of Roentgenology. 205: 899-904. PMID 26397342 DOI: 10.2214/Ajr.14.13804 |
0.402 |
|
| 2015 |
Parsons M, Goldman D, Dashevsky B, Riedl CC, Gonen M, Osborne J, Jochelson M, Hudis C, Morrow M, Ulaner G. Value of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Breast Cancer (ILC) as Compared with Invasive Ductal Breast Cancer (IDC). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26294295 DOI: 10.2967/Jnumed.115.161455 |
0.426 |
|
| 2015 |
Jhaveri K, Ulaner GA, Dickler MN. Predictive Value of Positron Emission Tomography/Computed Tomography to Assess Early Treatment Response to Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade Without Chemotherapy for HER2-Positive Metastatic Breast Cancer: Are We Ready to Embrace This "Early Metabolic Look" Strategy? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 2591-3. PMID 26195716 DOI: 10.1200/Jco.2015.62.3082 |
0.343 |
|
| 2015 |
Ulaner GA, Riedl CC. Reply: Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1293-4. PMID 26112021 DOI: 10.2967/Jnumed.115.161042 |
0.401 |
|
| 2015 |
Ulaner GA, Goldman DA, Sauter CS, Migliacci J, Lilienstein J, Gönen M, Schöder H, Moskowitz CH, Zelenetz AD. Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma. Radiology. 142556. PMID 26035588 DOI: 10.1148/Radiol.2015142556 |
0.374 |
|
| 2015 |
Dashevsky BZ, Goldman DA, Parsons M, Gönen M, Corben AD, Jochelson MS, Hudis CA, Morrow M, Ulaner GA. Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype. European Journal of Nuclear Medicine and Molecular Imaging. PMID 25971426 DOI: 10.1007/S00259-015-3080-Z |
0.424 |
|
| 2015 |
Sauter CS, Matasar MJ, Meikle J, Schoder H, Ulaner GA, Migliacci JC, Hilden P, Devlin SM, Zelenetz AD, Moskowitz CH. Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma. Blood. 125: 2579-81. PMID 25758829 DOI: 10.1182/Blood-2014-10-606939 |
0.35 |
|
| 2015 |
Pinker K, Riedl C, Ong L, Jochelson MS, Ulaner G, Dickler MN, Weber W. Is response classification with PERCIST in stage IV breast cancer influenced by the number of lesions assessed? Journal of Clinical Oncology. 33: e12004-e12004. DOI: 10.1200/Jco.2015.33.15_Suppl.E12004 |
0.427 |
|
| 2015 |
Shah PD, Chandarlapaty S, Dickler MN, Ulaner G, Zamora SJ, Sterlin V, Iasonos A, Coughlin CM, Morozov A, Ero J, Rosen N, Gilewski T, Fornier MN, Sklarin NT, Berger MF, et al. Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC). Journal of Clinical Oncology. 33: 590-590. DOI: 10.1200/Jco.2015.33.15_Suppl.590 |
0.308 |
|
| 2015 |
Riedl C, Pinker K, Ong L, Jochelson MS, Ulaner G, McArthur HL, Dickler MN, Weber W. FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients. Journal of Clinical Oncology. 33: 1051-1051. DOI: 10.1200/Jco.2015.33.15_Suppl.1051 |
0.43 |
|
| 2014 |
Riedl CC, Slobod E, Jochelson M, Morrow M, Goldman DA, Gonen M, Weber WA, Ulaner GA. Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1578-83. PMID 25214641 DOI: 10.2967/Jnumed.114.143297 |
0.435 |
|
| 2014 |
Beylergil V, Simmons MZ, Ulaner G, Jurcic J, Hibshoosh H, Carrasquillo JA. FDG PET/CT findings in a rare case of giant fibrovascular polyp of the esophagus harboring atypical lipomatous tumor/well-differentiated liposarcoma. Clinical Nuclear Medicine. 39: 288-91. PMID 24458178 DOI: 10.1097/Rlu.0000000000000358 |
0.388 |
|
| 2014 |
Ulaner GA, Lilienstein J, Gönen M, Maragulia J, Moskowitz CH, Zelenetz AD. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 51-6. PMID 24248697 DOI: 10.1200/Jco.2013.50.8044 |
0.33 |
|
| 2013 |
Ulaner GA, Eaton A, Morris PG, Lilienstein J, Jhaveri K, Patil S, Fazio M, Larson S, Hudis CA, Jochelson MS. Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer. Cancer Medicine. 2: 725-33. PMID 24403238 DOI: 10.1002/Cam4.119 |
0.358 |
|
| 2013 |
Ulaner GA, Lyall A. Identifying and distinguishing treatment effects and complications from malignancy at FDG PET/CT. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 33: 1817-34. PMID 24108564 DOI: 10.1148/Rg.336125105 |
0.412 |
|
| 2013 |
Mojtahedi A, Grewal RK, Ulaner GA. FDG-avid venous malformation could mimic malignancy on 18F-FDG PET/CT. Clinical Nuclear Medicine. 38: 826-8. PMID 24107816 DOI: 10.1097/Rlu.0B013E3182A20Dd5 |
0.406 |
|
| 2013 |
Ulaner GA, D'Andrea G, Cody HS. Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT. Clinical Nuclear Medicine. 38: 480-1. PMID 23640240 DOI: 10.1097/Rlu.0B013E31828E98Dc |
0.388 |
|
| 2013 |
Ulaner G, Hwang S, Landa J, Lefkowitz RA, Panicek DM. Musculoskeletal tumours and tumour-like conditions: common and avoidable pitfalls at imaging in patients with known or suspected cancer: Part B: malignant mimics of benign tumours. International Orthopaedics. 37: 877-82. PMID 23417556 DOI: 10.1007/S00264-013-1824-6 |
0.308 |
|
| 2013 |
Mojtahedi A, Solomon SB, Ulaner GA. Focused regional FDG PET/CT detects more osseous metastases than does whole-body PET/CT. Clinical Nuclear Medicine. 38: 217-8. PMID 23357824 DOI: 10.1097/Rlu.0B013E31827A27Ae |
0.396 |
|
| 2013 |
Ulaner GA, Tewari S. Hill-Sachs lesion on FDG PET/CT. Clinical Nuclear Medicine. 38: 65-6. PMID 23242054 DOI: 10.1097/Rlu.0B013E318270865C |
0.368 |
|
| 2013 |
Hatzoglou V, Ulaner GA, Zhang Z, Beal K, Holodny AI, Young RJ. Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients. Clinical Imaging. 37: 451-7. PMID 23068052 DOI: 10.1016/J.Clinimag.2012.08.008 |
0.397 |
|
| 2012 |
Lyall A, Ulaner GA. False-positive FDG PET/CT due to liver parenchymal injury caused by a surgical retractor. Clinical Nuclear Medicine. 37: 910-1. PMID 22889789 DOI: 10.1097/Rlu.0B013E31825B23C0 |
0.381 |
|
| 2012 |
Lyall A, Vargas HA, Carvajal RD, Ulaner G. Ipilimumab-induced colitis on FDG PET/CT. Clinical Nuclear Medicine. 37: 629-30. PMID 22614208 DOI: 10.1097/Rlu.0B013E318248549A |
0.393 |
|
| 2012 |
Morris PG, Ulaner GA, Eaton A, Fazio M, Jhaveri K, Patil S, Evangelista L, Park JY, Serna-Tamayo C, Howard J, Larson S, Hudis CA, McArthur HL, Jochelson MS. Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer. Cancer. 118: 5454-62. PMID 22517371 DOI: 10.1002/Cncr.27579 |
0.403 |
|
| 2011 |
Morris PG, Fazio M, Jhaveri KL, Serna-Tamayo C, Eaton A, Patil S, Ulaner G, Howard J, Larson SM, Hudis C, Jochelson MS, McArthur HL. Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 567. PMID 28021437 DOI: 10.1200/jco.2011.29.15_suppl.567 |
0.301 |
|
| 2011 |
Jhaveri KL, Ulaner G, Fazio M, Eaton A, Patil S, Evangelista L, Serna-Tamayo C, McArthur HL, Hudis C, Morris PG. Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3. PMID 27958173 DOI: 10.1200/jco.2011.29.27_suppl.3 |
0.303 |
|
| 2011 |
Lu Y, Ulaner G. FDG PET/CT demonstration of right atrium metastasis overlooked on contrast-enhanced CT. Clinical Nuclear Medicine. 36: 405-6. PMID 21467869 DOI: 10.1097/Rlu.0B013E31820Adf10 |
0.384 |
|
| 2008 |
Ulaner GA, Colletti PM, Conti PS. B-cell non-Hodgkin lymphoma: PET/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy--initial experience. Radiology. 246: 895-902. PMID 18258810 DOI: 10.1148/Radiol.2463060588 |
0.38 |
|
| 2006 |
Padmanabhan P, Otero J, Ray P, Paulmurugan R, Hoffman AR, Gambhir SS, Biswal S, Ulaner GA. Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 270-7. PMID 16455633 |
0.432 |
|
| 2005 |
Li T, Vu TH, Ulaner GA, Littman E, Ling JQ, Chen HL, Hu JF, Behr B, Giudice L, Hoffman AR. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. Molecular Human Reproduction. 11: 631-40. PMID 16219628 DOI: 10.1093/Molehr/Gah230 |
0.488 |
|
| 2005 |
Littman E, Ling J, Ulaner G, Vu T, Dasig D, Lyon J, Giudice L, Hoffman A, Behr B. Effect of GMCSF on Development and Gene Imprinting in Preimplantation Mouse Embryos Fertility and Sterility. 83: S8. DOI: 10.1016/J.Fertnstert.2005.01.013 |
0.452 |
|
| 2004 |
Ulaner GA, Hoffman AR, Otero J, Huang HY, Zhao Z, Mazumdar M, Gorlick R, Meyers P, Healey JH, Ladanyi M. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Genes, Chromosomes & Cancer. 41: 155-62. PMID 15287028 DOI: 10.1002/Gcc.20074 |
0.49 |
|
| 2004 |
Yao X, Hu JF, Li T, Yang Y, Sun Z, Ulaner GA, Vu TH, Hoffman AR. Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors. Cancer Genetics and Cytogenetics. 151: 1-13. PMID 15120907 DOI: 10.1016/J.Cancergencyto.2003.08.021 |
0.528 |
|
| 2004 |
Li T, Vu TH, Ulaner GA, Yang Y, Hu JF, Hoffman AR. Activating and silencing histone modifications form independent allelic switch regions in the imprinted Gnas gene. Human Molecular Genetics. 13: 741-50. PMID 14962976 DOI: 10.1093/Hmg/Ddh081 |
0.48 |
|
| 2004 |
Littman E, Ulaner G, Vu T, Otero J, Dasig D, Lyon J, Gebhardt J, Giudice L, Behr B, Hoffman A. Igf2 Gene imprinting in preimplantation mouse embryos Fertility and Sterility. 81: 14-15. DOI: 10.1016/J.Fertnstert.2004.02.039 |
0.458 |
|
| 2003 |
Yang Y, Hu JF, Ulaner GA, Li T, Yao X, Vu TH, Hoffman AR. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites. Journal of Cellular Biochemistry. 90: 1038-55. PMID 14624463 DOI: 10.1002/Jcb.10684 |
0.494 |
|
| 2003 |
Yang Y, Li T, Vu TH, Ulaner GA, Hu JF, Hoffman AR. The histone code regulating expression of the imprinted mouse Igf2r gene. Endocrinology. 144: 5658-70. PMID 12975326 DOI: 10.1210/En.2003-0798 |
0.476 |
|
| 2003 |
Ulaner GA, Yang Y, Hu JF, Li T, Vu TH, Hoffman AR. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues. Endocrinology. 144: 4420-6. PMID 12960026 DOI: 10.1210/En.2003-0681 |
0.493 |
|
| 2003 |
Ulaner GA, Huang HY, Otero J, Zhao Z, Ben-Porat L, Satagopan JM, Gorlick R, Meyers P, Healey JH, Huvos AG, Hoffman AR, Ladanyi M. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Research. 63: 1759-63. PMID 12702558 |
0.427 |
|
| 2003 |
Ulaner GA, Vu TH, Li T, Hu JF, Yao XM, Yang Y, Gorlick R, Meyers P, Healey J, Ladanyi M, Hoffman AR. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Human Molecular Genetics. 12: 535-49. PMID 12588801 DOI: 10.1093/Hmg/Ddg034 |
0.489 |
|
| 2001 |
Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. International Journal of Cancer. Journal International Du Cancer. 91: 644-9. PMID 11267974 DOI: 10.1002/1097-0215(200002)9999:9999<::Aid-Ijc1103>3.0.Co;2-V |
0.477 |
|
| 2000 |
Hu JF, Ulaner GA, Oruganti H, Ivaturi RD, Balagura KA, Pham J, Vu TH, Hoffman AR. Allelic expression of the putative tumor suppressor gene p73 in human fetal tissues and tumor specimens. Biochimica Et Biophysica Acta. 1491: 49-56. PMID 10760569 DOI: 10.1016/S0167-4781(00)00017-8 |
0.491 |
|
| 2000 |
Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. International Journal of Cancer. Journal International Du Cancer. 85: 330-5. PMID 10652422 DOI: 10.1002/(Sici)1097-0215(20000201)85:3<330::Aid-Ijc6>3.0.Co;2-U |
0.484 |
|
| 1998 |
Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Research. 58: 4168-72. PMID 9751630 |
0.426 |
|
| 1997 |
Ulaner GA, Giudice LC. Developmental regulation of telomerase activity in human fetal tissues during gestation. Molecular Human Reproduction. 3: 769-73. PMID 9358002 DOI: 10.1093/Molehr/3.9.769 |
0.302 |
|
| Show low-probability matches. |